Ardelyx (ARDX) Depreciation and Depletion (2014 - 2022)
Ardelyx's (ARDX) quarterly Depreciation and Depletion came in at $175000.0 in Q2 2022, down 52.05% YoY from $365000.0 in Q2 2021, and down 24.57% on a QoQ basis from $232000.0 in Q1 2022.
Ardelyx (ARDX) Depreciation and Depletion (2014 - 2022) Analysis & Trends
Ardelyx (ARDX) has 9 years of Depreciation and Depletion data on file, last reported at $175000.0 in Q2 2022.
- Quarterly Depreciation and Depletion fell 52.05% year-over-year to $175000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1.0 million (down 37.31% YoY) and the FY2025 annual result came in at $800000.0, up 60.0% from the prior year.
- Depreciation and Depletion eased to $175000.0 in Q2 2022, from $232000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $678000.0 in Q2 2019 to a low of $153000.0 in Q4 2021.
- A 5-year average of $488111.1 and a median of $480000.0 in 2020 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2018 — Depreciation and Depletion grew 13.47% — and 2021, when it tumbled 61.85%.
- Tracing ARDX's Depreciation and Depletion over 5 years: stood at $673000.0 in 2018, then fell by 24.52% to $508000.0 in 2019, then decreased by 21.06% to $401000.0 in 2020, then plunged by 61.85% to $153000.0 in 2021, then grew by 14.38% to $175000.0 in 2022.
- The last three Depreciation and Depletion figures came in at $175000.0 (Q2 2022), $232000.0 (Q1 2022), and $153000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 175,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Mar 31, 2020 | 492,000.00 |
| Mar 31, 2020 | 492,000.00 |